akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 107 blog entries.

MHRA Class 2 Medicines Recall: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd)

MHRA Class 2 Medicines Notification: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd) Drug alert number: EL(25)A/22 Date issued: 19 May 2025 Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This defect could increase the risk of the applicator device [...]

The post MHRA Class 2 Medicines Recall: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd) appeared first on Community Pharmacy England.

By |May 19th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd)

Promoting NHS prescription prepayment certificates

Pharmacy teams can help to raise awareness by displaying posters in their pharmacy to remind patients about the savings they can make with prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or when a patient is prescribed a listed HRT medicine. The cost of each type of PPC has been frozen for [...]

The post Promoting NHS prescription prepayment certificates appeared first on Community Pharmacy England.

By |May 14th, 2025|Lexpos News|Comments Off on Promoting NHS prescription prepayment certificates

MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Healthcare professionals should advise patients [...]

The post MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects appeared first on Community Pharmacy England.

By |May 7th, 2025|Lexpos News|Comments Off on MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects

£9.90 NHS prescription and PPC charges unchanged for May 2025

The Government is yet to conclude consideration of any increases to prescription charges and NHS prescription pre-payment certificates (PPCs) for 2025/26. Therefore, the current charges will roll over into May 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be [...]

The post £9.90 NHS prescription and PPC charges unchanged for May 2025 appeared first on Community Pharmacy England.

By |April 23rd, 2025|Lexpos News|Comments Off on £9.90 NHS prescription and PPC charges unchanged for May 2025

Update – Expiry of Government stockpile of Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets)

Update 03/07/2025 – Community Pharmacy England would like to remind pharmacy teams that the previous PIP code for ordering Paxlovid® stock is no longer operational. The current and correct PIP code for obtaining Paxlovid® stock is 435-2712. For more information, Pfizer can be contacted directly on 0345 608 8866 or via email at customer.services@pfizer.com. NHS England [...]

The post Update – Expiry of Government stockpile of Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) appeared first on Community Pharmacy England.

By |April 22nd, 2025|Lexpos News|Comments Off on Update – Expiry of Government stockpile of Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets)